Compounds > plerixafor
Page last updated: 2024-08-24

plerixafor and Liver Neoplasms

plerixafor has been researched along with Liver Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's8 (80.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Cai, J; Huang, BR; Lei, HW; Li, CM; Liao, ZY; Shang, CB; Wan, ZD1
Arteta, B; Benedicto, A; Romayor, I1
Zhao, ZF; Zhou, X; Zhu, WB1
Dai, Z; Fan, J; Sun, Q; Tan, C; Wang, Z; Xu, M; Zhou, J; Zhu, H1
Chen, Y; Chern, GG; Chiang, T; Gao, DY; Lin, TT; Liu, CH; Liu, JY1
Chen, J; Jia, H; Lu, L; Lu, M; Pei, Y; Qin, L; Zhu, W1
Chan, KM; Chen, Y; Chern, GG; Chiang, T; Hsu, FF; Liu, CH; Liu, JY; Liu, YC; Wu, YH1
Hussein Somi, M; Mardomi, A; Rahbarghazi, R; Sabzichi, M; Samadi, N; Shanehbandi, D; Taj Sanjarani, O1
Abe, H; Fujikura, Y; Ina, K; Kitamura, H; Sumiyoshi, H; Tatsukawa, S; Yoshioka, H1
Chen, Y; Feng, GS; Fu, J; He, YQ; Li, YQ; Li, Z; Lin, Y; Liu, Q; Tang, L; Wang, C; Wang, HY; Wu, FQ; Wu, MC; Yan, HX; Yang, W; Yu, LX; Zhang, HL; Zheng, LY; Zou, SS1

Other Studies

10 other study(ies) available for plerixafor and Liver Neoplasms

ArticleYear
CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma.
    The Kaohsiung journal of medical sciences, 2022, Volume: 38, Issue:8

    Topics: Animals; Benzylamines; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclams; Liver Neoplasms; Rats; Receptors, CXCR4; Vascular Endothelial Growth Factor A

2022
CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
    Oncology reports, 2018, Volume: 39, Issue:4

    Topics: Animals; Benzylamines; Cancer-Associated Fibroblasts; Cell Movement; Cell Proliferation; Chemokine CXCL12; Colorectal Neoplasms; Cyclams; Gene Expression Regulation, Neoplastic; Hepatic Stellate Cells; Heterocyclic Compounds; Humans; Liver Neoplasms; Mice; Receptors, CXCR4; Signal Transduction; Stromal Cells; Tumor Microenvironment; Xenograft Model Antitumor Assays

2018
AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
    Journal of cellular physiology, 2019, Volume: 234, Issue:7

    Topics: Animals; Benzylamines; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Chemokine CXCL12; Cyclams; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Liver Neoplasms; Lung Neoplasms; Male; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; Phosphorylation; Prostatic Neoplasms; Receptors, CXCR4; RNA, Messenger; Signal Transduction

2019
Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo.
    Molecular medicine reports, 2014, Volume: 10, Issue:2

    Topics: Animals; Benzylamines; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Immunohistochemistry; Immunosuppressive Agents; Liver Neoplasms; Lymphatic Metastasis; Rats; Receptors, CXCR4; Tacrolimus

2014
Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2015, Volume: 23, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Disease Progression; Genetic Therapy; Heterocyclic Compounds; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Nanoparticles; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Sorafenib; Tumor Microenvironment; Vascular Endothelial Growth Factor A

2015
Down-regulation of SDF1-α expression in tumor microenvironment is associated with aspirin-mediated suppression of the pro-metastasis effect of sorafenib in hepatocellular carcinoma.
    Acta biochimica et biophysica Sinica, 2015, Volume: 47, Issue:12

    Topics: Animals; Aspirin; Benzylamines; Carcinoma, Hepatocellular; Cell Proliferation; Chemokine CXCL12; Cyclams; Down-Regulation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Heterocyclic Compounds; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Niacinamide; Phenylurea Compounds; Receptors, CXCR4; Sorafenib; Tumor Microenvironment

2015
Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
    Molecular pharmaceutics, 2016, 07-05, Volume: 13, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cyclams; Disease Models, Animal; Disease Progression; Hepatic Stellate Cells; Heterocyclic Compounds; Humans; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Nanoparticles; Neovascularization, Pathologic; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor A

2016
Trafficking mechanism of bone marrow-derived mesenchymal stem cells toward hepatocellular carcinoma HepG2 cells by modulating Endoglin, CXCR4 and TGF-β.
    Cellular and molecular biology (Noisy-le-Grand, France), 2016, Sep-30, Volume: 62, Issue:11

    Topics: Benzamides; Benzylamines; Blotting, Western; Bone Marrow Cells; Carcinoma, Hepatocellular; Cell Movement; Chemokine CXCL12; Culture Media, Conditioned; Cyclams; Endoglin; Hep G2 Cells; Heterocyclic Compounds; Humans; Liver Neoplasms; Mesenchymal Stem Cells; Pyrazoles; Real-Time Polymerase Chain Reaction; Receptors, CXCR4; rhoA GTP-Binding Protein; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta

2016
Role of the CXCL12/CXCR4 axis in milky spots of rats bearing ascitic-type hepatoma.
    Anatomical science international, 2009, Volume: 84, Issue:3

    Topics: Alkaline Phosphatase; Animals; Benzylamines; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis; Cyclams; Green Fluorescent Proteins; Heterocyclic Compounds; Immunohistochemistry; Liver Neoplasms; Male; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Omentum; Peritoneal Neoplasms; Rats; Rats, Sprague-Dawley; Receptors, CXCR4

2009
OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
    Journal of hepatology, 2012, Volume: 57, Issue:3

    Topics: AC133 Antigen; Animals; Antigens, CD; Antigens, Differentiation; Antigens, Neoplasm; Benzylamines; Carcinoma, Hepatocellular; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cyclams; Disease Progression; Disease-Free Survival; Epithelial Cell Adhesion Molecule; Female; Gene Knockdown Techniques; Glycoproteins; Heterocyclic Compounds; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Middle Aged; Multivariate Analysis; Neoplasm Invasiveness; Neoplastic Stem Cells; Peptides; Prognosis; Receptors, CXCR4; RNA, Small Interfering; Spheroids, Cellular

2012